Skip to main content
Login
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published • loading... • Updated

Globus Medical: 7 Quarters Of Margin Expansion, Priced For None (NYSE:GMED)

Summary by Seeking Alpha
Globus Medical is rated a buy, targeting a 17.5% return over four quarters with a constant 10.56x EV/EBITDA multiple. Click here to read this GMED stock update.

1 Articles

Seeking AlphaSeeking Alpha
Lean Right

Globus Medical: 7 Quarters Of Margin Expansion, Priced For None (NYSE:GMED)

Globus Medical is rated a buy, targeting a 17.5% return over four quarters with a constant 10.56x EV/EBITDA multiple. Click here to read this GMED stock update.

·Ra'anana, Israel
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Right
100% Right

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Seeking Alpha broke the news in Ra'anana, Israel on Wednesday, August 19, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Electric Vehicles icon

Electric Vehicles

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal